Vaneck Etf Price Prediction Breakdown

BBH -  USA Etf  

USD 196.16  1.71  0.86%

Vaneck Biotech ETF etf price prediction is an act of determining the future value of Vaneck Biotech shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Vaneck Biotech's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Vaneck Biotech and does not consider all of the tangible or intangible factors available from Vaneck Biotech's fundamental data. We analyze noise-free headlines and recent hype associated with Vaneck Biotech ETF, which may create opportunities for some arbitrage if properly timed.
Continue to Vaneck Biotech Basic Forecasting Models to cross-verify your projections.

Vaneck Price Prediction 

 
Refresh
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Vaneck Biotech based on different types of headlines from major news networks to social media. The Vaneck price prediction module provides an analysis of price elasticity to changes in media outlook on Vaneck Biotech over a specific investment horizon. Using Vaneck Biotech hype-based prediction, you can estimate the value of Vaneck Biotech ETF from the perspective of Vaneck Biotech response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Vaneck Biotech. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Vaneck Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying Vaneck because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Vaneck Biotech after-hype prediction price

    
  $ 196.16  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Vaneck Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Vaneck Biotech in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
177.03178.51215.78
Details
Naive
Forecast
LowNext ValueHigh
206.26207.74209.22
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
188.75195.36201.97
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Vaneck Biotech. Your research has to be compared to or analyzed against Vaneck Biotech's peers to derive any actionable benefits. When done correctly, Vaneck Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Vaneck Biotech ETF.

Vaneck Biotech After-Hype Price Prediction Density Analysis

As far as predicting the price of Vaneck Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Vaneck Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Vaneck Biotech, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Vaneck Biotech Estimiated After-Hype Price Volatility

In the context of predicting Vaneck Biotech's etf value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Vaneck Biotech's historical news coverage. Vaneck Biotech's after-hype downside and upside margins for the prediction period are 194.68 and 197.64, respectively. We have considered Vaneck Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
196.16
23rd of October 2021
194.68
Downside
196.16
After-hype Price
197.64
Upside
Vaneck Biotech is very steady asset. Analysis and calculation of next after-hype price of Vaneck Biotech ETF is based on 3 months time horizon.

Vaneck Biotech Etf Price Prediction Analysis

Have you ever been surprised when a price of a ETF such as Vaneck Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vaneck Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Vaneck Biotech, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.04  1.48  0.00   0.00  0 Events / Month0 Events / MonthIn 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
196.16196.160.00 
0.00  

Vaneck Biotech Hype Timeline

On the 23rd of October Vaneck Biotech ETF is traded for 196.16. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Vaneck forecasted not to react to the next headlinewith price going to stay at about the same level and average media hype impact volatility of about 0.0%. The immediate return on the next newsis forecasted to be very small whereas the daily expected return is currently at -0.04%. The volatility of relative hype elasticity to Vaneck Biotech is about 0.0%. The volatility of related hype on Vaneck Biotech is about 0.0% with expected price after next announcement by competition of 196.16. Considering the 90-day investment horizon the next forecastedpress releasewill be in 5 to 10 days.
Continue to Vaneck Biotech Basic Forecasting Models to cross-verify your projections.

Vaneck Biotech Related Hype Analysis

Having access to credible news sources related to Vaneck Biotech's direct competition is more important than ever and may enhance your ability to predict Vaneck Biotech's future price movements. Getting to know how Vaneck Biotech rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Vaneck Biotech may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
US Medical Devices 0.00 0 per month 0.97  0.05  1.34 (1.50)  3.68 

Vaneck Biotech Additional Predictive Modules

Most predictive techniques to examine Vaneck price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vaneck using various technical indicators. When you analyze Vaneck charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Vaneck Biotech Predictive Indicators

The successful prediction of Vaneck Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Vaneck Biotech ETF, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Vaneck Biotech based on analysis of Vaneck Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Vaneck Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Vaneck Biotech's related companies.

Story Coverage note for Vaneck Biotech

The number of cover stories for Vaneck Biotech depends on current market conditions and Vaneck Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Vaneck Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Vaneck Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Vaneck Biotech Short Properties

Vaneck Biotech's future price predictability will typically decrease when Vaneck Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Vaneck Biotech ETF often depends not only on the future outlook of the potential Vaneck Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vaneck Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
Average Daily Volume Last 10 Day14.26k
Average Daily Volume In Three Month16.01k
Continue to Vaneck Biotech Basic Forecasting Models to cross-verify your projections. Note that the Vaneck Biotech ETF information on this page should be used as a complementary analysis to other Vaneck Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for Vaneck Etf analysis

When running Vaneck Biotech ETF price analysis, check to measure Vaneck Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaneck Biotech is operating at the current time. Most of Vaneck Biotech's value examination focuses on studying past and present price action to predict the probability of Vaneck Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vaneck Biotech's price. Additionally, you may evaluate how the addition of Vaneck Biotech to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
The market value of Vaneck Biotech ETF is measured differently than its book value, which is the value of Vaneck that is recorded on the company's balance sheet. Investors also form their own opinion of Vaneck Biotech's value that differs from its market value or its book value, called intrinsic value, which is Vaneck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaneck Biotech's market value can be influenced by many factors that don't directly affect Vaneck Biotech ETF underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaneck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Vaneck Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaneck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.